Status:
UNKNOWN
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
Lead Sponsor:
Capital Medical University
Conditions:
Invasive Pulmonary Aspergillosis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether inhalation with aerosolized amphoterin B 10mg/d is more effective than aerosolized amphoterin B 2mg/d to reduce the incidence of invasive pulmonary as...
Eligibility Criteria
Inclusion
- 65ys≥age≥18ys
- renal transplant recipients
Exclusion
- subjects with hypersensitivity to amphotericin B
- receipt of inhalational or intravenous amphotericin B within last 30 days
- subjects with known invasive fungal infection before renal transplant
- subjects with pneumonia
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00986713
Start Date
June 1 2008
End Date
October 1 2010
Last Update
September 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Chaoyang Hospital,Affiliate of Capital Medical University
Beijing, Beijing Municipality, China, 100020